Splenectomy in plasma cell dyscrasias: A review of the clinical practice

被引:10
作者
Kapoor, Prashant
Singh, Ekta
Radhakrishnan, Priya
Mehta, Paulette
机构
[1] Univ N Dakota, MeritCare Hosp, Sch Med & Hlth Sci, Dept Internal Med, Fargo, ND 58122 USA
[2] Univ Arizona, Coll Med, Dept Med, Phoenix, AZ USA
[3] Univ Arkansas Med Sci, Dept Hematol & Oncol, Little Rock, AR 72205 USA
[4] Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA
关键词
multiple myeloma; plasmacytomas; AL amyloidosis; Waldenstrom's macro-globulinemia; factor X deficiency;
D O I
10.1002/ajh.20736
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma cell dyscrasias are a group of clinically and biochemically diverse disorders of unknown etiology, characterized by the disproportionate proliferation of one or more clones of B cells, and the presence of a structurally and electrophoretically homogeneous (monoclonal) immunoglobulin or polypeptide subunit in serum or urine. The role of splenectomy in the management of plasma cell dyscrasias has not been well defined. Using MEDLINE, the authors searched the English-language published literature from the year 1970 through September 2005 to determine the indications for splenectomy in plasma cell dyscrasias. A review of the literature in humans and animals supported the idea that the spleen provides a special microenvironment favorable for homing or differentiation of IgM producing B cells, and splenectomy can, at times, lead to remission in Waldenstrom's macroglobulinemia. The other reported reasons for splenectomy in plasma cell dyscrasias are hypersplenism-related pancytopenia, control of splenic plasmacytomas, and management of a splenic abscess. Splenic infiltration in primary amyloidosis can be an indication for splenectomy, where removal of a large spleen can also reverse an acquired factor X deficiency. Thus, the spleen can be considered a potential target organ for management of plasma cell dyscrasias, and therapeutic success has been achieved with removal of this organ. However, splenectomy can be a potentially morbid procedure in patients with plasma cell dyscrasias, and major postoperative complications include infection, hemorrhage, and thrombosis.
引用
收藏
页码:946 / 954
页数:9
相关论文
共 53 条
  • [1] PRIMARY AMYLOIDOSIS
    BARTH, WF
    GLENNER, GG
    WALDMANN, TA
    ZELIS, RF
    [J]. ANNALS OF INTERNAL MEDICINE, 1968, 69 (04) : 787 - +
  • [2] Recombinant human factor VIIa in the management of amyloid-associated factor X deficiency
    Boggio, L
    Green, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (04) : 1074 - 1075
  • [3] Splenectomy in an uraemic patient with acquired factor X deficiency due to AL amyloidosis
    Bohrer, H
    Waldherr, R
    Martin, E
    Linke, RP
    Lin, J
    Ziegler, R
    Ritz, E
    Nawroth, PP
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (01) : 190 - 193
  • [4] HEMORRHAGIC SYNDROME IN WALDENSTROMS MACROGLOBULINEMIA SECONDARY TO IMMUNOADSORPTION OF FACTOR-VIII - RECOVERY AFTER SPLENECTOMY
    BRODY, JI
    HAIDAR, ME
    ROSSMAN, RE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (08) : 408 - 410
  • [5] Advanced Waldenstrom's macroglobulinemia:: A case of possible cure after systemic chemotherapy, splenic radiation and splenectomy
    Cavanna, L
    Bertè, R
    Lazzaro, A
    Vallisa, D
    Moroni, CF
    Civardi, G
    [J]. ACTA HAEMATOLOGICA, 2002, 108 (02) : 97 - 101
  • [6] CHOI YJ, 1979, AM J CLIN PATHOL, V71, P121
  • [7] Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy
    Choufani, EB
    Sanchorawala, V
    Ernst, T
    Quillen, K
    Skinner, M
    Wright, DG
    Seldin, DC
    [J]. BLOOD, 2001, 97 (06) : 1885 - 1887
  • [8] CHARACTERIZATION OF AMYLOID DEPOSITS AND P COMPONENT FROM A PATIENT WITH FACTOR-X DEFICIENCY REVEALS PROTEINS DERIVED FROM A LAMBDA-VI LIGHT CHAIN
    COHEN, D
    PRAS, M
    FRANKLIN, EC
    FRANGIONE, B
    [J]. AMERICAN JOURNAL OF MEDICINE, 1983, 74 (03) : 513 - 518
  • [9] Non-secretory solitary plasmacytoma of the spleen
    Colovic, M
    Jankovic, GM
    Colovic, RB
    Martinovic-Cemerikic, VM
    [J]. MEDICAL ONCOLOGY, 1998, 15 (04) : 286 - 288
  • [10] WALDENSTROMS MACROGLOBULINEMIA IN A PATIENT WITH A CHRONIC BIOLOGIC FALSE-POSITIVE SEROLOGIC TEST FOR SYPHILIS
    DRUSIN, LM
    LITWIN, SD
    ARMSTRONG, D
    WEBSTER, BP
    [J]. AMERICAN JOURNAL OF MEDICINE, 1974, 56 (03) : 429 - 432